TrialInternational journal of clinical oncology2019

mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.

Masamichi Yasuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.